Literature DB >> 499286

Placebos and controlled trials under attack.

L Lasagna.   

Abstract

Mesh:

Substances:

Year:  1979        PMID: 499286     DOI: 10.1007/bf00561733

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  3 in total

1.  The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials.

Authors:  J A Freiman; T C Chalmers; H Smith; R R Kuebler
Journal:  N Engl J Med       Date:  1978-09-28       Impact factor: 91.245

2.  Editorial: A plea for the "naturalistic" study of medicines.

Authors:  L Lasagna
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

3.  Controlled clinical trials and medical ethics.

Authors:  R Burkhardt; G Kienle
Journal:  Lancet       Date:  1978 Dec 23-30       Impact factor: 79.321

  3 in total
  8 in total

1.  Placebo effect and placebos: what are we talking about? Some conceptual and historical considerations.

Authors:  Ana Macedo; Magí Farré; Josep-E Baños
Journal:  Eur J Clin Pharmacol       Date:  2003-06-27       Impact factor: 2.953

Review 2.  Rationale for and methods of superiority, noninferiority, or equivalence designs in orthopaedic, controlled trials.

Authors:  Patrick Vavken
Journal:  Clin Orthop Relat Res       Date:  2011-01-19       Impact factor: 4.176

Review 3.  Anaesthetic premedication: aims, assessment and methods.

Authors:  T H Madej; R T Paasuke
Journal:  Can J Anaesth       Date:  1987-05       Impact factor: 5.063

4.  Basic problems in controlled trials.

Authors:  R Burkhardt; G Kienle
Journal:  J Med Ethics       Date:  1983-06       Impact factor: 2.903

5.  Placebos and other comparative treatments.

Authors:  C R Joyce
Journal:  Br J Clin Pharmacol       Date:  1982-03       Impact factor: 4.335

6.  Bias in the elucidation of subjective side-effects.

Authors:  L Lasagna
Journal:  Br J Clin Pharmacol       Date:  1981       Impact factor: 4.335

7.  A naturalistic study of hypertension in a rural U.K. community. 2 Years results.

Authors:  P J Fell; J M Shakespeare; N P Watson; H F O'Donnell
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 8.  Placebo and the Helsinki Declaration--what to do?

Authors:  Bozidar Vrhovac
Journal:  Sci Eng Ethics       Date:  2004-01       Impact factor: 3.525

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.